tiprankstipranks
Trending News
More News >
Satellos Bioscience Inc. (MSCLF)
:MSCLF
US Market

Satellos Bioscience (MSCLF) Income Statement

Compare
23 Followers

Satellos Bioscience Income Statement

Last quarter (Q4 2024), Satellos Bioscience's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Satellos Bioscience's net income was C$-6.11M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -20.00KC$ -8.82MC$ -3.73MC$ -119.92KC$ -48.16K
Operating Expenses
C$ 27.79MC$ 15.46MC$ 8.43MC$ 4.70MC$ 1.43M
Depreciation and Amortization
C$ 20.00KC$ 7.00KC$ 337.00KC$ 165.69KC$ 422.00
EBITDA
C$ -28.08MC$ -15.71MC$ -8.09MC$ -4.60MC$ -1.61M
Operating Income
C$ -27.81MC$ -15.46MC$ -8.43MC$ -4.74MC$ -1.55M
Other Income/Expenses
C$ -291.00KC$ -426.00KC$ -2.89MC$ -8.86MC$ 349.79K
Pretax Income
C$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51MC$ -1.58M
Net Income
C$ -28.10MC$ -15.89MC$ -11.32MC$ -15.51MC$ -1.58M
Per Share Metrics
Basic EPS
C$ -0.24C$ -0.18C$ -0.32C$ -0.64C$ -0.05
Diluted EPS
C$ -0.24C$ -0.18C$ -0.32C$ -0.64C$ -0.05
Weighted Average Shares Outstanding
114.78M 86.40M 35.68M 24.08M 32.87M
Weighted Average Shares Outstanding (Diluted)
114.78M 86.40M 35.68M 24.08M 32.87M
Currency in CAD

Satellos Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis